|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 3019191 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14748342.4 |
| Date of filing the European patent application | 2014-07-10 | |
| (97) | Date of publication of the European application | 2016-05-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation | 2020-03-10 |
| (86) | Number | PCT/US2014/046170 |
| Date | 2014-07-10 |
| (87) | Number | WO 2015/006571 |
| Date | 2015-01-15 |
| (30) | Number | Date | Country code |
| 201361844978 P | 2013-07-11 | US |
| (72) |
KOSTIC, Ana, US
KELLY, Ludmila, US
LIU, Xia, US
CLASSON, Brendan J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Eozinofilinio ezofagito gydymo būdai, skiriant IL-4 inhibitorių |
| METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 12 | 289.00 EUR |
| 2026-07-10 |